Safety evaluation of cephalosporins based on utilization and adverse drug events: analysis of two databases in China

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Expert Opinion on Drug Safety

• Publication date

  2012-08-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1517/14740338.2012.699037PMID 22708900
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Application analysis of antibiotics in our hospital

  2013cited by this paper
• The use of cephalosporins in penicillin-allergic patients: a literature review.

  2012cited by this paper
• Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features.

  2011cited by this paper
• Outcomes of emergency department patients presenting with adverse drug events.

  2011cited by this paper
• Hospital antibiotic consumption in Switzerland: comparison of a multicultural country with Europe.

  2011influential reference
• Patient knowledge and antibiotic abuse: Evidence from an audit study in China.

  2011cited by this paper
• Clostridium difficile infections in China

  2010cited by this paper
• Application analysis of antibiotics in our hospital in 2009

  2010cited by this paper
• Use of Antibiotics in Shanghai Second and Third Level Hospitals During the Period of 2007-2008

  2010cited by this paper
• Analysis of 612 Cases of Antibiotics-induced ADR in Our Hospital

  2010cited by this paper
• Relationship of Antibacterials Use and Bacterial Drug Resistance in Hospitalized Patients

  2010cited by this paper
• Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.

  2010cited by this paper
• Optimizing antimicrobial prescribing.

  2010cited by this paper
• Algorithms for assessing the probability of an Adverse Drug Reaction

  2009cited by this paper
• Learning from our history.

  2008cited by this paper
• Antimicrobial stewardship: concepts and strategies in the 21st century.

  2008cited by this paper
• Adverse events associated with the use of oral cephalosporins/cephems.

  2007cited by this paper
• Antimicrobial stewardship and the role of pharmacokinetics-pharmacodynamics in the modern antibiotic era.

  2007cited by this paper
• Immediate allergic reactions to cephalosporins: evaluation of cross-reactivity with a panel of penicillins and cephalosporins.

  2006cited by this paper
• Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

  2006cited by this paper
• Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.

  2004cited by this paper
• Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003.

  2004cited by this paper
• Antibiotic use in German university hospitals 1998-2000 (Project INTERUNI-II).

  2004influential reference
• Rational antibiotic use and academic staff.

  2003cited by this paper
• Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory

  2001cited by this paper
• How the US Food and Drug Administration Defines and Detects Adverse Drug Events

  2001cited by this paper
• Cefaclor revisited.

  2000cited by this paper
• Principles of selection and use of antimicrobial agents

  1999cited by this paper
• [The new cephalosporins].

  1996cited by this paper
• Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins.

  1995cited by this paper

• Hypersensitivity to Cefpodoxime Resulting in Toxic Epidermal Necrolysis in an Infant: A Case Report

  2026cites this paper
• Pharmacovigilance Strategies to Address Resistance to Antibiotics and Inappropriate Use—A Narrative Review

  2024cites this paper
• Quanduzhong capsules for the treatment of grade 1 hypertension patients with low-to-moderate risk: A multicenter, randomized, double-blind, placebo-controlled clinical trial

  2023cites this paper
• Cefodizime: pharmacological characteristics and potential for clinical use in lower respiratory tract infections

  2023cites this paper
• Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients

  2023cites this paper
• A cross-sectional study on knowledge and behavior regarding medication usage among guardians of left-behind children: evidence from China

  2023cites this paper
• Efficacy of Different Waste and By-Products from Forest and Food Industries in the Removal/Retention of the Antibiotic Cefuroxime

  2021cites this paper
• Diagnosis and management of protracted bacterial bronchitis: a survey of Chinese pediatricians

  2020cites this paper
• World Journal of Clinical Cases Hemophagocytic syndrome as a complication of acute pancreatitis: A case report

  2020cites this paper
• Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia

  2020cites this paper
• Hemophagocytic syndrome as a complication of acute pancreatitis: A case report.

  2020cites this paper
• Preparation of metal-organic framework based carbon materials and its application to adsorptive removal of cefepime from aqueous solution.

  2020cites this paper
• Modélisation des interventions pharmaceutiques hospitalières : de l'approche pharmacoépidémiologique à partir de l'observatoire français Act-IP© vers une diffusion d'un modèle de pratiques au Liban

  2019cites this paper
• Utilization and Safety of Hepatoprotective Drugs: A Retrospective Pharmacoepidemiology Study on Two Databases of China

  2017cites this paper
• Adverse Drug Reaction Monitoring in a North Indian Public Teaching Hospital

  2016cites this paper
• Adverse reactions associated with oral and parenteral use of cephalosporins: A retrospective population-based analysis.

  2015cites this paper